Protein aggregation and its affecting mechanisms in neurodegenerative diseases
Neurochemistry International · 2024-11 · 180 · 105880
DOI: 10.1016/j.neuint.2024.105880 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2024-11. Verfasst von Junyun Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Care Unit, Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Program of Zhejiang Province, Science and Technology Department of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Protein aggregation serves as a critical pathological marker in a spectrum of neurodegenerative diseases (NDs), including the formation of amyloid β (Aβ) and Tau neurofibrillary tangles in Alzheimer's disease, as well as α-Synuclein (α-Syn) aggregates in Parkinson's disease, Parkinson's disease-related dementia (PDD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). A significant proportion of patients with amyotrophic lateral sclerosis (ALS) exhibit TDP-43 aggregates. Moreover, a confluence of brain protein pathologies, such as Aβ, Tau, α-Syn, and TDP-43, has been identified in individual NDs cases, highlighting the intricate interplay among these proteins that is garnering heightened scrutiny. Importantly, protein aggregation is modulated by an array of factors, with burgeoning evidence suggesting that it frequently results from perturbations in protein homeostasis, influenced by the cellular membrane milieu, metal ion concentrations, post-translational modifications, and genetic mutations. This review delves into the pathological underpinnings of protein aggregation across various NDs and elucidates the intercommunication among disparate proteins within the same disease context. Additionally, we examine the pathogenic mechanisms by which diverse factors impinge upon protein aggregation, offering fresh perspectives for the future therapeutic intervention of NDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Care Unit, Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China.
- Department of Neurosurgery, Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China.
- Neuroscience Care Unit, Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China. Electronic address: 11718347@zju.edu.cn.
- Neuroscience Care Unit, Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China. Electronic address: renreng1203@zju.edu.cn.
Förderung
- Science and Technology Program of Zhejiang Province
- Science and Technology Department of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Wu, J., Chen, T., Cai, J., & Ren, R. (2024). Protein aggregation and its affecting mechanisms in neurodegenerative diseases. Neurochemistry International, 180, 105880. https://doi.org/10.1016/j.neuint.2024.105880
Vancouver
Wu J, Wu J, Chen T, Cai J, Ren R. Protein aggregation and its affecting mechanisms in neurodegenerative diseases. Neurochemistry International. 2024;180:105880. doi:10.1016/j.neuint.2024.105880
BibTeX
@article{Wu2024,
author = {Wu, Junyun and Wu, Jianan and Chen, Tao and Cai, Jing and Ren, Reng},
title = {Protein aggregation and its affecting mechanisms in neurodegenerative diseases},
journal = {Neurochemistry International},
year = {2024},
volume = {180},
pages = {105880},
doi = {10.1016/j.neuint.2024.105880}
}
EUVIMED